TY - JOUR
T1 - Magnetic resonance imaging based superficial femoral artery velocity measurements in peripheral artery disease
AU - Sinharoy, Ankita
AU - Reddy, Neeti
AU - Lin, John Kent
AU - Nambi, Vijay
AU - Yang, Eric Y.
AU - Kougias, Panagiotis
AU - Taylor, Addison A.
AU - Lumsden, Alan B.
AU - Ballantyne, Christie M.
AU - Morrisett, Joel D.
AU - Brunner, Gerd
N1 - Funding Information:
Gerd Brunner reports financial support was provided by National Institutes of Health. Gerd Brunner reports financial support was provided by American Heart Association.
Funding Information:
We thank all study patients for their participation. This work received support from the National Institutes of Health ( R01HL137763 , K25HL121149 both to GB), and the American Heart Association ( 13BGIA16720014 to GB).
Publisher Copyright:
© 2022 Elsevier Inc.
PY - 2022/11
Y1 - 2022/11
N2 - Peripheral artery disease (PAD) causes lower extremity dysfunction and is associated with an increased risk of cardiovascular mortality and morbidity. In this study, we analyzed how non-invasive 2-dimensional-phase-contrast magnetic resonance imaging (2D-PC-MRI) measured velocity markers of the distal superficial femoral artery (SFA) are associated with clinical and functional characteristics of PAD. A total of 70 (27 diabetic and 43 non-diabetic) PAD patients were included in this secondary analysis of data collected from the Effect of Lipid Modification on Peripheral Artery Disease after Endovascular Intervention Trial (ELIMIT). Electrocardiographically (ECG)-gated 2D-PC-MRI was performed at a proximal and a distal imaging location of the distal SFA. Baseline characteristics did not differ between diabetic and non-diabetic PAD patients. Claudication onset time (COT) was shorter in diabetic PAD patients compared to non-diabetics (0.56 (inter quartile range (IQR): 0.3, 2.04) minutes vs. 1.30 (IQR: 1.13, 2.15) minutes, p = 0.025). In a pooled analysis of all 70 PAD patients, maximum velocity was significantly higher in the proximal compared with the distal SFA segment (43.97 (interquartile range (IQR): 20.4, 65.2) cm/s; vs. 34.9 (IQR: 16.87, 51.71) cm/s; p < 0.001). The maximum velocities in both the proximal and distal SFA segments were significantly higher in diabetic PAD patients compared with non-diabetics (proximal: 53.6 (IQR: 38.73, 89.43) cm/s vs. 41.49 (IQR: 60.75, 15.9) cm/s, p = 0.033; distal: 40.8 (IQR: 23.7, 71.90) cm/s vs. 27.4 (IQR: 41.67, 12.54) cm/s, p = 0.012). Intra-observer variability, as assessed by intraclass correlation (ICC) analysis, was excellent for SFA mean and maximum velocities (0.996 (confidence interval [CI]: 0.996, 0.997); 0.999 (CI: 0.999, 0.999)). In conclusion, 2D-PC-MRI SFA velocity measures are reproducible and may be of interest in assessing diabetic and non-diabetic PAD patients.
AB - Peripheral artery disease (PAD) causes lower extremity dysfunction and is associated with an increased risk of cardiovascular mortality and morbidity. In this study, we analyzed how non-invasive 2-dimensional-phase-contrast magnetic resonance imaging (2D-PC-MRI) measured velocity markers of the distal superficial femoral artery (SFA) are associated with clinical and functional characteristics of PAD. A total of 70 (27 diabetic and 43 non-diabetic) PAD patients were included in this secondary analysis of data collected from the Effect of Lipid Modification on Peripheral Artery Disease after Endovascular Intervention Trial (ELIMIT). Electrocardiographically (ECG)-gated 2D-PC-MRI was performed at a proximal and a distal imaging location of the distal SFA. Baseline characteristics did not differ between diabetic and non-diabetic PAD patients. Claudication onset time (COT) was shorter in diabetic PAD patients compared to non-diabetics (0.56 (inter quartile range (IQR): 0.3, 2.04) minutes vs. 1.30 (IQR: 1.13, 2.15) minutes, p = 0.025). In a pooled analysis of all 70 PAD patients, maximum velocity was significantly higher in the proximal compared with the distal SFA segment (43.97 (interquartile range (IQR): 20.4, 65.2) cm/s; vs. 34.9 (IQR: 16.87, 51.71) cm/s; p < 0.001). The maximum velocities in both the proximal and distal SFA segments were significantly higher in diabetic PAD patients compared with non-diabetics (proximal: 53.6 (IQR: 38.73, 89.43) cm/s vs. 41.49 (IQR: 60.75, 15.9) cm/s, p = 0.033; distal: 40.8 (IQR: 23.7, 71.90) cm/s vs. 27.4 (IQR: 41.67, 12.54) cm/s, p = 0.012). Intra-observer variability, as assessed by intraclass correlation (ICC) analysis, was excellent for SFA mean and maximum velocities (0.996 (confidence interval [CI]: 0.996, 0.997); 0.999 (CI: 0.999, 0.999)). In conclusion, 2D-PC-MRI SFA velocity measures are reproducible and may be of interest in assessing diabetic and non-diabetic PAD patients.
KW - Arterial blood flow velocity
KW - Atherosclerosis
KW - Diabetes mellitus
KW - Magnetic resonance imaging
KW - Peripheral artery disease
KW - Superficial femoral artery
KW - Magnetic Resonance Imaging
KW - Lower Extremity/pathology
KW - Humans
KW - Thigh/pathology
KW - Peripheral Arterial Disease/diagnostic imaging
KW - Femoral Artery/diagnostic imaging
UR - http://www.scopus.com/inward/record.url?scp=85135922508&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85135922508&partnerID=8YFLogxK
U2 - 10.1016/j.mri.2022.08.003
DO - 10.1016/j.mri.2022.08.003
M3 - Article
C2 - 35940380
AN - SCOPUS:85135922508
SN - 0730-725X
VL - 93
SP - 128
EP - 134
JO - Magnetic Resonance Imaging
JF - Magnetic Resonance Imaging
ER -